ARTICLE | Regulation
Wake-up call
Narcolepsy patients tell FDA they want a better balance of alertness and sleep
September 30, 2013 7:00 AM UTC
Narcolepsy patients told FDAand companies at the agency's latest patient-focused drug development meeting they want a better balance of alertness and sleep. Specifically, this means better resolution of excessive daytime sleepiness - their worst symptom - and reductions in the sleep disruption side effects associated with current drugs.
It remains to be seen whether anything in the narcolepsy pipeline can achieve that balance...